Research
Hormonal
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) provide potent weight reduction among persons with overweight/obesity and show cardiovascular benefits.
GLP-1 RAs may be considered as a therapeutic option for weight management in patients with HIV and obesity.
StrongSupportsmedium confidence
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are well recognized to provide potent weight reduction among persons with overweight/obesity; in addition, studies have shown cardiovascular benefit among those with established cardiovascular disease.
Why this rating
The claim is based on a review of existing studies.
Source
Weighing In: Glucagon-Like Peptide-1 Receptor Agonism for Persons With HIV.
Teressa S Thomas et al. · PubMed · 2024
reviewCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →